Insight begins with access.
That’s what drives Ascilion.

At Ascilion we are singularly focused on solving one of medicine’s big challenges: providing real-time access to molecular biomarkers.

With this comes:

Real insight into personal health and wellness.
The ability to detect and help manage disease.
Real-world data needed for artificial intelligence to make real advances in predicting disease.

We see a future where molecular biomarker monitoring is ubiquitous, personal, and essential - where we all can follow the biomarkers that matter most to us, at every stage of our lives.

Ascilion's story

Ascilion was founded in 2012 with a mission to solve the problem of sampling dermal interstitial fluid in an efficient and pain-free way. A team of engineers with deep experience in MEMS technology and microfluidics took on the challenge of solving what turned out to be a very complex problem.

We exist to bridge the worlds of precision engineering and biomarker science, creating innovative microneedle technologies that make dISF accessible, reliable, and painless; empowering researchers, clinicians, and companies to unlock the full potential of health monitoring and diagnostics.

Ascilion's story

Ascilion was founded in 2012 with a mission to solve the problem of sampling dermal interstitial fluid in an efficient and pain-free way. A team of engineers with deep experience in MEMS technology and microfluidics took on the challenge of solving what turned out to be a very complex problem.

We exist to bridge the worlds of precision engineering and biomarker science, creating innovative microneedle technologies that make dISF accessible, reliable, and painless; empowering researchers, clinicians, and companies to unlock the full potential of health monitoring and diagnostics.


Ascilion's story

Ascilion was founded in 2012 with a mission to solve the problem of sampling dermal interstitial fluid in an efficient and pain-free way. A team of engineers with deep experience in MEMS technology and microfluidics took on the challenge of solving what turned out to be a very complex problem.

We exist to bridge the worlds of precision engineering and biomarker science, creating innovative microneedle technologies that make dISF accessible, reliable, and painless; empowering researchers, clinicians, and companies to unlock the full potential of health monitoring and diagnostics.
‍


A highly experienced team

The team at Ascilion has an exceptional level of competence in critical technical areas and broad experience within product development and commercialization. The team’s collective experience in selected areas can be summarized as:

25+
strategic, long-term partnerships
100+
product development projects
40
years of combined MEMS experience
50+
medical device commercialization programs
70+
regulatory submissions led globally


News

Dermal interstitial fluid:
Abundant. Biomarker-rich.
Notoriously difficult to extract.

Link

Have a question, a study, or a bold idea?
Let's start the conversation.

Contact us
HomeTechnologyProductsSampling for wearablesAbout us
Postal address
Ascilion AB, P.O. Box 1263
SE-164 29 Kista, Sweden

Visiting address
Isafjordsgatan 22
SE-164 40 Kista, Sweden